Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 65, Issue 2, 2006, Pages 269-271

  Naito, Y ^a   Matsumoto, I ^a   Wakamatsu, E ^a   Goto, D ^a   Ito, S ^a   Tsutsumi, A ^a   Sumida, T ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; LIGAND; MUSCARINIC RECEPTOR; PEPTIDE AA[213-237]; PEPTIDE AA[216-230]; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ARTICLE; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHARMACOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; PARAPLEGIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MOTIF; RECEPTOR BINDING; RISK FACTOR; SEQUENCE ANALYSIS; SJOEGREN SYNDROME; SPASTICITY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE RECEPTOR GENE;

HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; LIGANDS; PEPTIDE FRAGMENTS; RECEPTOR, MUSCARINIC M3; SJOGREN'S SYNDROME; T-LYMPHOCYTES;

EID: 31144439287     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.039065     Document Type: Article

References (9)

1. Sumida T, Matsumoto I, Maeda T, Nishioka K. T-cell receptor in Sjögren's syndrome. Br J Rheumatol 1997;36:622-9.
2. Sumida T, Namekawa T, Maeda T, Nishioka K. New T-cell epitope of Ro/SS-A 52kD protein in labial salivary glands from patients with Sjögren's syndrome. Lancet 1996;348:1667.
3. Halse AK, Wahren M, Jonsson R. Peripheral blood in Sjogren's syndrome does not contain increased levels of T lymphocytes reactive with the recombinat Ro/SS-A 52 kD and La/SS-B 48kD autoantigens. Autoimmunity 1996;23:25-34.
4. Gordon TP, Bolstad AI, Rischmueller M, Jonsson R, Waterman SA. Autoantibodies in primary Sjogren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity 2001;34:123-32.
5. Naito Y, Matsumoto I, Wakamatsu E, Goto D, Sugiyama T, Matsumura R, et al. Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome. Ann Rheum Dis 2005;64:510-11.
6. Magistris MTD, Alexander J, Coggeshall M, Altman A, Gaeta FCA, Grey HM, et al. Antigen analog-major histo-compatibility complexes act as antagonists of the T cell receptor. Cell 1992;68:625-34.
7. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995;181:1569-74.
8. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjogren's syndrome (1999): availability and validity. Mod Rheumatol 2004;14:425-34.
9. Vitali C, Bomvardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. European study group on classification criteria for Sjögren's syndrome. Ann Rheum Dis 2002;61:554-8.